Top Sin Stocks to Buy Now for Power, Predictability & Long-Term Gains
Sin stocks stand out as resilient plays, blending stable demand, pricing power and strategic shifts that support long-term growth potential.
Nicotine Pouches Hit 55.7% of Oral Tobacco: Where Does Altria Stand?
Nicotine pouches dominate 55.7% of the oral market, raising pressure on MO as on! loses share and on! PLUS rolls out to boost its position.
Is Turning Point Brands Stock a Buy After Investment Firm Cannell Capital Raises Its Stake to Nearly $20 Million?
Investment advisor Cannell Capital LLC reported a substantial increase in its holdings of Turning Point Brands ( NYSE:TPB ) , according to a United States Securities and Exchange Commission ( SEC ) filing dated November 14, 2025.The fund added 119,821 shares during the third quarter, bringing ...
Is Monster Beverage ( MNST ) Outperforming Other Consumer Staples Stocks This Year?
Here is how Monster Beverage (MNST) and Turning Point Brands (TPB) have performed compared to their sector so far this year.
Should You Bet on Altria Stock After Its Q3 Earnings Report?
MO is backed by strong fundamentals, pricing power and long-term growth potential in smoke-free products.
Ballast Dumps 34,000 Turning Point Brands Stock Worth $3.1 Million
Turning Point Brands remains a mid-sized holding, placing it outside the fund's top five positions.
Can KT&G Alliance Drive Altria's Next Global Growth Phase?
MO's alliance with KT&G aims to accelerate its global push into modern oral nicotine and smoke-free products.
Altria Oral Tobacco Margins Hit 69%: Pricing Power or Mix Shift?
MO's oral tobacco unit hits a 69% margin in the third quarter, powered by pricing discipline and cost control despite volume declines.
Turning Point Brands ( TPB ) Q3 Earnings and Revenues Beat Estimates
Turning Point Brands (TPB) delivered earnings and revenue surprises of +29.63% and +5.90%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Altria's on! PLUS Launch Fuels Oral Tobacco Profit Gains: What's Next?
MO's Helix unit drives margin gains as new on! PLUS nicotine pouches launch in key states amid tough pricing pressure.
Altria's on! PLUS Launch Fuels Oral Tobacco Profit Gains: What's Next?
MO's Helix unit drives margin gains as new on! PLUS nicotine pouches launch in key states amid tough pricing pressure.
Altria ( MO ) Tops Q3 Earnings Estimates
Altria (MO) delivered earnings and revenue surprises of +0.69% and -1.32%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Turning Point Brands ( TPB ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Turning Point Brands (TPB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Consider Buying Altria Stock Before Q3 Earnings Release?
MO's Q3 results are likely to gain strength from pricing power, cost discipline and growing smoke-free momentum.
MO Optimize & Accelerate Initiative: Enough to Boost Long-Term EPS?
Altria's Optimize & Accelerate program reinvests cost savings to fuel smoke-free growth and long-term EPS.
Philip Morris ( PM ) Surpasses Q3 Earnings and Revenue Estimates
Philip Morris (PM) delivered earnings and revenue surprises of +6.67% and +1.32%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Altria Rises 12% in 3 Months: Should You Buy, Sell or Hold the Stock?
MO's 12% 3-month surge highlights strong earnings, rising smoke-free sales and disciplined execution amid industry weakness.
Altria's Oral Margins Surge to 68.7%: Can the Strength Last?
MO's oral segment OCI margin hits 68.7% as on! pouches boost profitability despite volume dips and rising competition.
Zacks Industry Outlook Highlights Philip Morris International, Altria and Turning Point Brands
Despite declining cigarette sales, Philip Morris International, Altria, and Turning Point Brands are driving growth through smoke-free innovations and shifting consumer trends.
3 Tobacco Stocks to Keep an Eye on Amid Industry Challenges
PM, MO and TPB are navigating declining cigarette sales and rising health awareness through smoke-free innovations and strategic portfolio expansion.
MO's on! Hits 8.7% Oral Tobacco Share: Can It Fend Off Competitors?
Altria's on! nicotine pouch brand captures 8.7% of the U.S. oral tobacco market, fueling growth and brand momentum in a fierce competitive landscape.
Altria Delivers 7.2% EPS Growth in 1H25 Despite Sales Headwinds
MO's first half of 2025 EPS grows 7.2% to $2.67 despite revenue declines, as pricing, efficiency gains and buybacks lifted margins and returns.
Altria Stock Trading at a Discount: What's the Next Best Move?
MO shows steady earnings and strong pricing power, though long-term momentum depends on balancing cigarette declines with smoke-free gains.
Altria Returns $4 Billion to Shareholders in First Half of 2025
MO has returned more than $4 billion to its shareholders in early 2025, fueled by strong dividends, buybacks and a solid balance sheet.
Mo's Smoke-Free Vision vs. Cigarette Declines: Is Transition on Track?
Altria shows cigarette volumes sliding while on! nicotine pouches surge in the second quarter, spotlighting the gradual shift toward smoke-free growth.
FDA To Expedite Nicotine Pouch Reviews In Pilot Program Under Trump Pressure: Report - Altria Group ( NYSE:MO ) , British American Tobacco ( NYSE:BTI )
The U.S. Food and Drug Administration ( FDA ) is reportedly set to launch a pilot program to fast-track the review of nicotine pouches from four major tobacco companies amid mounting pressure from the Trump administration.
Can on! Help Altria Capture More of the Booming Pouch Market?
MO's on! shipments jumped 26.5% in the second quarter, lifting its U.S. pouch share as marketing and earnings momentum intensify in a fast-growing market.
Should First Trust Dow Jones Select MicroCap ETF ( FDM ) Be on Your Investing Radar?
Style Box ETF report for ...
Philip Morris Transformation Accelerates With IQOS and ZYN Growth
PM's second-quarter results show smoke-free gains lifting revenues and profit, even as cigarette volumes continue to decline.
What's Driving Altria Group's Growth in OCI for Smokeables?
MO's smokeable margins jumped 2.9 percentage points to 64.5% as pricing power and cost cuts offset sharp volume declines.
Stoker's Launches Fine Cut Wintergreen in Convenient Can Format - Turning Point Brands ( NYSE:TPB )
LOUISVILLE, Ky., Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Stoker's®, a leading brand in premium smokeless tobacco, has launched its popular Fine Cut Wintergreen in a convenient 1.2-ounce can, now in 15 states.
Altria Bets on Pricing: A Cushion Against Falling Volumes?
MO uses pricing strength to cushion profits against steep drops in cigarette volumes.
Should You Buy Altria Stock as it Hits a New 52-Week High?
MO hits a 52-week high on earnings growth, oral tobacco gains and rising investor confidence in its long-term strategy.
PM Stock Trades at Premium Value: Should You Buy, Hold or Sell?
Philip Morris' smoke-free growth is strong, but cigarette declines and a premium valuation urge cautious investment moves.
Philip Morris Aims for $2B Cost Savings by 2026: How Close Is It?
PM has already captured $1.2 billion in savings by mid-2025, keeping it on track to hit its $2 billion cost-cutting target by 2026.
Sin Stocks Worth Watching: The Perfect Mix of Growth & Resilience
Sin stocks like alcohol, tobacco and gambling remain resilient, offering stable demand, strong dividends and growth despite regulation and controversy.
Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth? ( Revised )
ILUMA's broader launch and expanded consumables range are contributing to PM's heated tobacco growth in 2025.
Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth?
ILUMA's broader launch and expanded consumables range are contributing to PM's heated tobacco growth in 2025.
Is on! Brand Growth Enough to Offset MST Declines at Altria?
MO's on! sales jump in the second quarter, but MST declines and pouch share losses raise questions about sustaining growth.
Turning Point ( TPB ) Q2 Sales Jump 25%
Turning Point Brands ( NYSE:TPB ) , the consumer products company known for its iconic tobacco and cannabis accessories brands, released its results for Q2 2025 on August 6, 2025. The quarter saw the company surpass Wall Street expectations with GAAP revenue of $116.6 million, well above the GAAP ...
MO Expands Smoke-Free Portfolio: Can It Offset Combustible Declines?
Altria's on! nicotine pouch shipments surge 26.5% in the second quarter, but can smoke-free gains offset cigarette declines?
Turning Point Brands ( TPB ) Q2 Earnings and Revenues Surpass Estimates
Turning Point Brands (TPB) delivered earnings and revenue surprises of +24.05% and +10.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
VEEV Volumes Double: Will Philip Morris' E-Vapor Bet Pay Off?
PM's VEEV shipments have more than doubled in the second quarter, with Europe driving growth and new markets showing early promise.
This Incyte Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday - Turning Point Brands ( NYSE:TPB ) , Incyte ( NASDAQ:INCY )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst Gerald Pascarelli initiated coverage on Turning Point Brands, Inc.
Can ZYN and IQOS Sustain Philip Morris' Smoke-Free Surge?
IQOS and ZYN power PM's smoke-free growth in Q2, now accounting for more than 40% of revenues and gross profit.
Will Strong Pricing Power Offset Altria's Volume Declines in 2025?
Altria leans on strong pricing and Marlboro's brand power to offset a drop in cigarette volumes in the second quarter.
Altria ( MO ) Q2 Earnings and Revenues Surpass Estimates
Altria (MO) delivered earnings and revenue surprises of +5.11% and +1.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Altria's Q2 Earnings on the Deck: How to Play the Stock
MO's Q2 results are likely to reflect NJOY ACE's market exit and soft cigarette volumes, though pricing strength may help.
Here's Why Philip Morris Raises Its 2025 EPS Guidance Again
PM hikes its 2025 EPS guidance as smoke-free products like IQOS and ZYN boost the second-quarter performance.
Is on! the Bright Spot in Altria's Oral Tobacco Portfolio?
With rising brand loyalty and expanding reach, on! is reshaping MO's future in the oral nicotine space.
